MLB Post-Break Injury Check: Judge, Scherzer and Woodruff Headline the Fantasy Risks

The All-Star break gave banged-up stars a chance to reset, and the reports coming out of it are a mixed bag for fantasy managers. Aaron Judge's rib has improved but he is not yet at full strength, Max Scherzer's rehab was shut down after a series of cortisone shots, and Brandon Woodruff's shoulder prognosis was described in cautious terms by his manager. Shohei Ohtani, meanwhile, took a maintenance injection and is on track to keep playing. Here is the second-half injury board that matters most for lineups and roster decisions.

Aaron Judge: improving, but not 100 percent

The most important name is Judge. Reporting indicates his rib improved based on imaging done during the break, but the slugger is not yet 100 percent and will need additional imaging before his status fully clarifies. That is an encouraging trend rather than a clean bill of health, and the distinction matters for fantasy managers deciding whether to hold, sit or explore trades.

The practical read: a healthier Judge is a top-of-the-board fantasy asset whose production single-handedly swings the AL leaderboard, so the direction of travel is the good news. But a rib issue can linger and sap power even when a player is in the lineup, so watch the follow-up imaging and monitor whether his batted-ball authority looks normal once he is back to a full workload. Do not sell low on a player of his caliber over an injury that is reportedly improving, but do temper expectations until the next round of imaging confirms he is trending toward full strength.

Max Scherzer: rehab shut down

Scherzer is the clearest sell-side signal on the board. His rehab was shut down during the week after he received multiple cortisone shots, with his manager confirming he got three shots in his right thumb in mid-July. A shut-down rehab combined with repeated cortisone injections is not the profile of a pitcher about to return on a predictable timeline, and fantasy managers should treat his rest-of-season availability as genuinely uncertain.

In redraft leagues, Scherzer is droppable in shallow formats where roster spots are scarce and streaming options exist. In deeper leagues, he is a stash only if you can afford to carry an injured pitcher with an unclear timeline. The upside if he returns is real given his track record, but the odds of a clean, on-schedule comeback took a hit with the rehab being paused, and fantasy decisions should reflect that.

Brandon Woodruff: a cloudy shoulder outlook

Woodruff's situation is the one to watch most closely for tone. His manager indicated that the shoulder, or at least the prognosis on it, is not good, a notably cautious framing that should give fantasy managers pause. Shoulder issues for pitchers are among the trickiest to time and the slowest to resolve, and a pessimistic public comment from the manager rarely precedes a quick return.

For fantasy, treat Woodruff as a hold-and-monitor in deeper leagues and a candidate to move on from in shallow ones unless a clear positive update emerges. The value if he returns healthy is significant, but the current signal is cautionary, and rostering him means accepting an uncertain timeline. Watch for any concrete update on his throwing progression before committing a roster spot to the wait.

Shohei Ohtani: the good-news exception

Not every report is a warning. Ohtani was in the lineup and took a lubricating injection in his knee during the break, a maintenance move rather than a red flag, and he is expected to keep playing on schedule. For fantasy managers, that is confirmation that the sport's most valuable player remains a set-and-forget asset in the second half. The injection is worth noting only as background; it does not change his outlook or his lineup status.

The betting angle

Star injuries move team totals and player props more than almost anything else in the daily market. A Judge who returns to full power raises the Yankees' run environment and his own home-run props; a Judge still hampered by a rib does the opposite, and the market may lag the reality either direction. Scherzer's and Woodruff's absences shift their teams' rotation projections and can soften team totals in the games their replacements start, which is a spot for bettors who track probable pitchers closely. In each case, the edge belongs to whoever reads the medical update before the number adjusts.

The Verdexed model take

Verdexed's model treats Judge as a hold with a positive trend, projecting his value to recover as the imaging improves and cautioning only that rib injuries can quietly cap power for a stretch even after a return. It flags Scherzer and Woodruff as the two clearest downgrades on the board: the model lowers their rest-of-season projections meaningfully given a paused rehab and a cautious shoulder prognosis, respectively, and it favors moving on in shallow leagues where the roster spot has better uses. Ohtani stays untouched at the top of the model's hitter and overall rankings, with the knee injection logged as maintenance rather than risk.

What to do in your league

Hold Judge and watch the follow-up imaging; do not sell low on an improving injury to a superstar. Cut or heavily discount Scherzer depending on league depth, and treat Woodruff the same way while monitoring for a concrete throwing update. Keep Ohtani locked in your lineup. And as always in the second half, let the medical reports drive the decisions, because the managers who react to the next update fastest are the ones who win the roster battles that decide close leagues.